Proteostasis Therapeutics Current Cash

Proteostasis Therapeutics (PTI) currently reports a current cash of $36M as of September 2020. That compares with $35M in the prior-year period — up 1.3% year over year. Use the charts on this page to explore Proteostasis Therapeutics's current cash history and peer comparisons.

Proteostasis Therapeutics's current cash increased from $35M to $36M — a 1.3% year-over-year increase (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Proteostasis Therapeutics reported $36M in current cash as of September 2020. That compares with $35M in the prior-year period — up 1.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $36M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Proteostasis Therapeutics, and consider following PTI for alerts when major investors trade the stock.

Proteostasis Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $36M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PTI with unrelated industries.